NEXGEL to Present at the LD Micro Main Event XIX Conference on October 19-21

NEXGEL, Inc. (NASDAQ: NXGL), a prominent provider of healthcare and beauty products featuring innovative high-water-content hydrogel technology, is poised to present at the LD Micro Main Event XIX Conference scheduled for October 19-21, 2025, at the Hotel Del Coronado in San Diego, California. Adam Levy, the company’s Chief Executive Officer, will deliver the presentation on October 20 at 11:30 a.m. PT.

The LD Micro Main Event is a renowned platform for emerging growth companies and is expected to attract significant investor attention. NEXGEL plans to utilize this opportunity to showcase its diverse range of products, including their well-regarded brands like SilverSeal®, Hexagels®, Turfguard®, Kenkoderm®, and Silly George®. These offerings highlight the company’s commitment to developing ultra-gentle, effective solutions in healthcare and consumer markets that leverage its expertise in hydrogel technology.

NEXGEL has established a solid reputation over the past two decades, designing and manufacturing electron-beam cross-linked hydrogels for various applications. Alongside its product portfolio, the company also maintains strategic partnerships with leading consumer healthcare companies, providing contract manufacturing capabilities that further enhance its market position.

Investors and interested parties wishing to engage in one-on-one meetings with Mr. Levy during the conference can reach out to KCSA Strategic Communications via email for scheduling.

For those unable to attend in person, a live webcast of Levy's presentation will be available, providing insights into NEXGEL's strategic direction and growth prospects. The company’s participation at such a prominent event underscores its dedication to innovation in the healthcare and beauty sectors, aiming to captivate potential investors and collaborators alike. For more information, visit their investor relations page at https://ir.nexgel.com/news-events/events-presentations.

NEXGEL, Inc. (NASDAQ: NXGL) is set to present at the LD Micro Main Event XIX Conference on October 20, 2025, a significant event that provides an opportunity for investors to glean insights from its CEO, Adam Levy. This conference is pivotal for NEXGEL as it aims to showcase its innovative hydrogel products designed for healthcare and consumer applications.

Investors should consider the implications of NEXGEL’s presentation within the context of the current market dynamics. The healthcare sector has been robust, driven by increasing consumer demand for high-quality, gentle, and effective healthcare products. NEXGEL’s specialized offerings, such as SilverSeal® and Hexagels®, could benefit from this trend, particularly given their unique formulation that caters to a growing demographic focused on personal health and wellness.

Additionally, NEXGEL's established relationships with leading consumer healthcare companies through strategic contract manufacturing could yield substantial revenue growth. As the market continues to favor companies that demonstrate innovation and quality, NEXGEL's two decades of prowess in developing electron-beam cross-linked hydrogels positions it favorably within its niche.

Investors attending the conference or virtual attendees should prepare to assess the company's plans for future product development and its strategy for scaling operations amidst increasing competition in the hydrogel market. Monitoring NEXGEL's performance at this event could offer insights into its commitment to growth and innovation.

In summary, keep an eye on NEXGEL as it presents at the LD Micro Main Event. The company’s performance post-conference and its ability to leverage emerging trends in the healthcare sector will be critical indicators of its future trajectory. Engaging with the company via the scheduled one-on-one investor meetings could yield further insights into their upcoming developments.